Skip to main content
Livermore
Livermore
ZHEN

Deep Track Capital, LP

SEC CIK
0001856083
Latest filing
Aug 14, 2026

Holdings in Q2 2023

Holdings as of Jun 30, 2023, filed Sep 6, 2023. Long positions only; changes compare share counts with Q1 2023.

Institution overview
Positions
53
−1 vs. Q1 2023
Portfolio value
$2.14B
−$210.6M (−9.0%) vs. Q1 2023
Filed
Sep 6, 2023
AmendedSEC
Holdings of Deep Track Capital, LP in Q2 2023
SecurityClassSharesValue% of portfolioShare changeActionHistory
JAZZJazz Pharmaceuticals plcSHS USD1,250,000$155.0M7.2%+50,000+4.2%AddedHistory
INSMINSMED IncCOM PAR $.016,500,000$137.2M6.4%00.0%UnchangedHistory
IONSIonis Pharmaceuticals IncCOM2,834,069$116.3M5.4%00.0%UnchangedHistory
TVTXTravere Therapeutics, Inc.COM7,370,000$113.2M5.3%+1,222,732+19.9%AddedHistory
GPCRStructure Therapeutics Inc.SPONSORED ADS2,646,782$110.0M5.1%00.0%UnchangedHistory
IMVTImmunovant, Inc.COM5,421,330$102.8M4.8%−2,011,387−27.1%ReducedHistory
ITCIIntra-Cellular Therapies, Inc.COM1,548,252$98.0M4.6%−151,748−8.9%ReducedHistory
ALKSAlkermes plc.SHS3,000,000$93.9M4.4%00.0%UnchangedHistory
SWTXSpringWorks Therapeutics, Inc.COM3,546,435$93.0M4.3%+446,435+14.4%AddedHistory
DVAXDynavax Technologies CorpCOM NEW6,557,816$84.7M4.0%+207,816+3.3%AddedHistory
GERNGeron CorpCOM24,170,966$77.6M3.6%−2,696,513−10.0%ReducedHistory
PLRXPliant Therapeutics, Inc.COM4,050,000$73.4M3.4%+627,943+18.3%AddedHistory
BCYCBicycle Therapeutics PLCSPONSORED ADS2,819,045$71.9M3.4%00.0%UnchangedHistory
VRNAVerona Pharma plcSPONSORED ADS3,187,415$67.4M3.1%00.0%UnchangedHistory
GHGuardant Health, Inc.COM1,500,000$53.7M2.5%+1,500,000NewHistory
FDMT4D Molecular Therapeutics, Inc.COM2,778,107$50.2M2.3%+500,000+21.9%AddedHistory
AGENAgenus IncCOM NEW30,000,000$48.0M2.2%00.0%UnchangedHistory
BEAMBeam Therapeutics Inc.COM1,317,316$42.1M2.0%+67,316+5.4%AddedHistory
AUTLAutolus Therapeutics plcSPON ADS15,000,000$35.7M1.7%00.0%UnchangedHistory
NTLAIntellia Therapeutics, Inc.COM835,446$34.1M1.6%+130,913+18.6%AddedHistory
VRDNViridian Therapeutics, Inc.COM1,279,502$30.4M1.4%+49,243+4.0%AddedHistory
NRIXNurix Therapeutics, Inc.COM2,997,830$29.9M1.4%00.0%UnchangedHistory
RPTXRepare Therapeutics Inc.COM2,727,606$28.9M1.3%00.0%UnchangedHistory
EDITEditas Medicine, Inc.COM3,453,744$28.4M1.3%+3,453,744NewHistory
DYNDyne Therapeutics, Inc.COM2,499,912$28.1M1.3%+165,279+7.1%AddedHistory
ANIPAni Pharmaceuticals IncCOM514,021$27.7M1.3%+514,021NewHistory
AXSMAxsome Therapeutics, Inc.COM384,200$27.6M1.3%+384,200NewHistory
PNTPOINT Biopharma Global Inc.COM2,781,565$25.2M1.2%+436,492+18.6%AddedHistory
EWTXEdgewise Therapeutics, Inc.COM2,750,000$21.3M1.0%−318,259−10.4%ReducedHistory
ZURAZura Bio LtdCLASS A ORD SHS2,523,000$20.7M1.0%+2,523,000NewHistory
PACBPacific Biosciences of California, Inc.COM1,451,201$19.3M0.9%−2,053,189−58.6%ReducedHistory
ABOSAcumen Pharmaceuticals, Inc.COM3,916,361$18.8M0.9%−35,639−0.9%ReducedHistory
RAPTRAPT Therapeutics, Inc.COM1,004,561$18.8M0.9%+433,328+75.9%AddedHistory
VIGLVigil Neuroscience, Inc.COM1,773,409$16.7M0.8%−251,728−12.4%ReducedHistory
ATXSAstria Therapeutics, Inc.COM1,697,415$14.1M0.7%−119,116−6.6%ReducedHistory
NUVBNuvation Bio Inc.COM CL A7,720,688$13.9M0.6%00.0%UnchangedHistory
MORFMorphic Holding, Inc.COM216,752$12.4M0.6%+216,752NewHistory
SLNSilence Therapeutics plcADS1,951,580$10.7M0.5%00.0%UnchangedHistory
ORTXOrchard Therapeutics plcADS2,041,670$10.6M0.5%+2,041,670NewHistory
NKTRNektar TherapeuticsCOM17,973,464$10.3M0.5%+16,230,216+931.0%AddedHistory
TERNTerns Pharmaceuticals, Inc.COM1,099,192$9.62M0.4%+1,099,192NewHistory
ETNB89bio, Inc.COM503,100$9.53M0.4%−1,296,900−72.1%ReducedHistory
INZYInozyme Pharma, Inc.COM1,644,021$9.16M0.4%−1,605,979−49.4%ReducedHistory
ZNTLZentalis Pharmaceuticals, Inc.COM300,300$8.47M0.4%+300,300NewHistory
RLMDRelmada Therapeutics, Inc.COM2,837,818$6.98M0.3%00.0%UnchangedHistory
GHRSGH Research PLCORDINARY SHARES499,400$5.93M0.3%00.0%UnchangedHistory
CMPSCOMPASS Pathways plcSPONSORED ADS678,360$5.62M0.3%+678,360NewHistory
MLTXMoonLake ImmunotherapeuticsCLASS A ORD108,450$5.53M0.3%+108,450NewHistory
IPSCCentury Therapeutics, Inc.COM1,022,892$3.23M0.2%00.0%UnchangedHistory
HRTXHeron Therapeutics, Inc.COM2,086,704$2.42M0.1%−1,148,018−35.5%ReducedHistory
ALLKAllakos Inc.COM228,277$995.3K<0.1%−3,356,723−93.6%ReducedHistory
IMUXImmunic, Inc.COM308,314$773.9K<0.1%−2,215,928−87.8%ReducedHistory
INKTMiNK Therapeutics, Inc.COM324,867$682.2K<0.1%+324,867NewHistory

Options (2)

Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.

Option positions of Deep Track Capital, LP in Q2 2023
SecurityClassPutsCalls
PRTAProthena Corp Public Ltd CoSHS$17.1M–
KYNBKyntra Bio, Inc.COM–$2.06M

Sold out since Q1 2023 (13)

Positions held at the end of Q1 2023 that are gone from this filing.

Positions of Deep Track Capital, LP sold out since Q1 2023
SecurityClassShares in Q1 2023Value in Q1 2023% of portfolio in Q1 2023History
ISEEIVERIC bio, Inc.COM6,500,000$158.1M6.7%History
KDNYChinook Therapeutics, Inc.COM3,000,000$69.5M3.0%History
RETAReata Pharmaceuticals IncCL A729,000$66.3M2.8%History
BIIBBiogen Inc.COM200,000$55.6M2.4%History
DICEDICE Therapeutics, Inc.COM1,600,000$45.8M1.9%History
EXELExelixis, Inc.COM1,931,874$37.5M1.6%History
DCPHDeciphera Pharmaceuticals, Inc.COM1,363,201$21.1M0.9%History
QUREuniQure N.V.SHS865,767$17.4M0.7%History
ACRSAclaris Therapeutics, Inc.COM1,708,971$13.8M0.6%History
JNCEJounce Therapeutics, Inc.COM4,259,653$7.88M0.3%History
ORTXOrchard Therapeutics plcSPON ADS NEW1,166,670$6.27M0.3%History
NKTXNkarta, Inc.COM1,354,200$4.81M0.2%History
TSVT2seventy bio, Inc.COMMON STOCK350,000$3.57M0.2%History